163 related articles for article (PubMed ID: 28245660)
1. Patients with diabetes in pay-for-performance programs have better physician continuity of care and survival.
Pan CC; Kung PT; Chiu LT; Liao YP; Tsai WC
Am J Manag Care; 2017 Feb; 23(2):e57-e66. PubMed ID: 28245660
[TBL] [Abstract][Full Text] [Related]
2. Pay-for-performance and continuity of care synergistically reduced amputation of lower extremity in patients with diabetes: a population-based cohort study.
Chen YC; Liao YH; Ku LE; Wang JD
BMC Health Serv Res; 2022 Jun; 22(1):748. PubMed ID: 35659668
[TBL] [Abstract][Full Text] [Related]
3. Effects of continuity of care on the postradiotherapy survival of working-age patients with oral cavity cancer: A nationwide population-based cohort study in Taiwan.
Kuo TJ; Wu PC; Tang PL; Yin CH; Chu CH; Hung YM
PLoS One; 2019; 14(12):e0225635. PubMed ID: 31841525
[TBL] [Abstract][Full Text] [Related]
4. Better continuity of care reduces costs for diabetic patients.
Chen CC; Chen SH
Am J Manag Care; 2011 Jun; 17(6):420-7. PubMed ID: 21756012
[TBL] [Abstract][Full Text] [Related]
5. Factors related to continuing care and interruption of P4P program participation in patients with diabetes.
Yen SM; Kung PT; Sheen YJ; Chiu LT; Xu XC; Tsai WC
Am J Manag Care; 2016 Jan; 22(1):e18-30. PubMed ID: 26799201
[TBL] [Abstract][Full Text] [Related]
6. Does the pay-for-performance programme reduce the emergency department visits for hypoglycaemia in type 2 diabetic patients?
Yu HC; Tsai WC; Kung PT
Health Policy Plan; 2014 Sep; 29(6):732-41. PubMed ID: 23894069
[TBL] [Abstract][Full Text] [Related]
7. Synergy between the pay-for-performance scheme and better physician-patient relationship might reduce the risk of retinopathy in patients with type 2 diabetes.
Chiou SJ; Liao K; Huang YT; Lin W; Hsieh CJ
J Diabetes Investig; 2021 May; 12(5):819-827. PubMed ID: 33025682
[TBL] [Abstract][Full Text] [Related]
8. Impact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study.
Chen YC; Lee CT; Lin BJ; Chang YY; Shi HY
Medicine (Baltimore); 2016 Jul; 95(27):e4197. PubMed ID: 27399144
[TBL] [Abstract][Full Text] [Related]
9. Effects and Factors Related to Adherence to A Diabetes Pay-for-Performance Program: Analyses of a National Health Insurance Claims Database.
Chi MJ; Chou KR; Pei D; Hwang JS; Quinn L; Chung MH; Liao YM
J Am Med Dir Assoc; 2016 Jul; 17(7):613-9. PubMed ID: 27073041
[TBL] [Abstract][Full Text] [Related]
10. Pay-for-performance programmes reduce stroke risks in patients with type 2 diabetes: a national cohort study.
Chou CW; Kung PT; Chou WY; Tsai WC
BMJ Open; 2019 Oct; 9(10):e026626. PubMed ID: 31619415
[TBL] [Abstract][Full Text] [Related]
11. Does pay-for-performance benefit patients with multiple chronic conditions? Evidence from a universal coverage health care system.
Chen CC; Cheng SH
Health Policy Plan; 2016 Feb; 31(1):83-90. PubMed ID: 25944704
[TBL] [Abstract][Full Text] [Related]
12. The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study.
Hsieh HM; Lin TH; Lee IC; Huang CJ; Shin SJ; Chiu HC
Prev Med; 2016 Apr; 85():53-59. PubMed ID: 26740347
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of diabetes pay-for-performance incentive designs.
Hsieh HM; Tsai SL; Shin SJ; Mau LW; Chiu HC
Med Care; 2015 Feb; 53(2):106-15. PubMed ID: 25397966
[TBL] [Abstract][Full Text] [Related]
14. The effect of pay for performance on risk incidence of hip fracture in type 2 diabetic patients: a nationwide population-based cohort study.
Lee YH; Kung PT; Kuo WY; Kao SL; Tsai WC
Medicine (Baltimore); 2020 Mar; 99(12):e19592. PubMed ID: 32195973
[TBL] [Abstract][Full Text] [Related]
15. A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan.
Hsieh HM; Chiu HC; Lin YT; Shin SJ
Int J Qual Health Care; 2017 Aug; 29(4):512-520. PubMed ID: 28531317
[TBL] [Abstract][Full Text] [Related]
16. Patient assessment of diabetes care in a pay-for-performance program.
Chiu HC; Hsieh HM; Lin YC; Kuo SJ; Kao HY; Yeh SC; Chang WH; Hsiao PJ; Chen YS; Lin SL; Lo GH; Ker CG; Hung YH; Cheng HA; Chou TH; Chou SY; Wang JH; Wang CF
Int J Qual Health Care; 2016 Apr; 28(2):183-90. PubMed ID: 26819445
[TBL] [Abstract][Full Text] [Related]
17. A Diabetes Pay-for-Performance Program and Risks of Cancer Incidence and Death in Patients With Type 2 Diabetes in Taiwan.
Hsieh HM; He JS; Shin SJ; Chiu HC; Lee CT
Prev Chronic Dis; 2017 Oct; 14():E88. PubMed ID: 28981404
[TBL] [Abstract][Full Text] [Related]
18. Effects of individual and neighborhood social risks on diabetes pay-for-performance program under a single-payer health system.
Tsai WC; Huang KH; Chen PC; Chang YC; Chen MS; Lee CB
Soc Sci Med; 2023 Jun; 326():115930. PubMed ID: 37146356
[TBL] [Abstract][Full Text] [Related]
19. Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage.
Liao PJ; Lin TY; Wang TC; Ting MK; Wu IW; Huang HT; Wang FC; Chang HC; Hsu KH
Medicine (Baltimore); 2016 Apr; 95(14):e3282. PubMed ID: 27057892
[TBL] [Abstract][Full Text] [Related]
20. Mortality and continuity of care - Definitions matter! A cohort study in diabetics.
Geroldinger A; Sauter SK; Heinze G; Endel G; Dorda W; Duftschmid G
PLoS One; 2018; 13(1):e0191386. PubMed ID: 29351547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
